Literature DB >> 7400298

Effects of antithyroid drugs on lymphocyte function in vitro.

B Hallengren, A Forsgren, A Melander.   

Abstract

The in vitro influence of 6-propylthiouracil (PTU) and methimazole (MMi) on mitogenic activation of human peripheral blood lymphocytes was studied in order to assess whether antithyroid drugs may have an immunomodulatory capacity. Lymphocytes were cultured for 72 h in the presence of phytohaemagglutinin (PHA; 1.25 microgram/ml), concanavalin A (Con A; 5.0 microgram/ml), or pokeweed mitogen (PWM; 2.5 microgram/ml). Antithyroid drugs were added to yield final concentrations of 1-1000 mu mol/liter. High pressure liquid chromatographic analyses verified that the expected drug concentrations in the incubation media were reached and maintained throughout the incubation period. The degree of lymphocyte activation was assessed by measurements of the cellular uptake of [3H]thymidine added after 48 h. PTU (at 1000 mu mol/liter) slightly suppressed PHA- and Con A-induced activation of lymphocytes but enhanced (at 5-500 mu mol/liter) PWM-induced activation. MMI (500-1000 mu mol/liter) enhanced not only PWM-induced activation but (at 1000 mu mol/liter) also enhanced PHA- and Con A-induced activation. Thus, PTU and MMI might interfere with mitogenic activation of lymphocytes. However, the effects were mainly recorded at drug concentrations exceeding those found in blood samples of patients treated with conventional doses.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7400298     DOI: 10.1210/jcem-51-2-298

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.

Authors:  F A Karlsson; T H Tötterman
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

Review 2.  Pharmacokinetics of antithyroid drugs.

Authors:  G Benker; D Reinwein
Journal:  Klin Wochenschr       Date:  1982-06-01

3.  Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.

Authors:  B Hallengren; O R Nilsson; B E Karlberg; A Melander; L Tegler; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  The effect of methimazole on the immune system is unlikely to operate directly on T lymphocytes.

Authors:  M Bagnasco; D Venuti; G Ciprandi; G Pesce; F Paolieri; G W Canonica
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

5.  Differential immunosuppressive action of carbimazole and propylthiouracil.

Authors:  R Wilson; J H McKillop; C Pearson; A K Burnett; J A Thomson
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

Review 6.  Clinical pharmacokinetics of antithyroid drugs.

Authors:  J P Kampmann; J M Hansen
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

7.  Inhibition of killer cell cytotoxicity induced by carbimazole in vitro.

Authors:  P Pozzilli; M Sensi; D Andreani
Journal:  J Endocrinol Invest       Date:  1982 May-Jun       Impact factor: 4.256

8.  Inhibition of the receptor for interleukin-2 induced by carbimazole: relevance for the therapy of autoimmune thyroid disease.

Authors:  A Signore; P Pozzilli; U Di Mario; M Sensi; P Beales; D Andreani
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

9.  Thyroid stimulating immunoglobulin bioactivity during carbimazole therapy as measured by the cytochemical bioassay.

Authors:  M G Prentice; G A Rayman; J Alaghband-Zadeh; P H Wise
Journal:  J Endocrinol Invest       Date:  1987-10       Impact factor: 4.256

10.  Spontaneous hypothyroidism after antithyroid treatment of hyperthyroid Graves' disease.

Authors:  B A Lamberg; J Salmi; G Wägar; T Mäkinen
Journal:  J Endocrinol Invest       Date:  1981 Oct-Dec       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.